Skip to main content
Signal8
Yonehiro Grant profile photo

Grant Yonehiro

CIK: 0001428666

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (10.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)15 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)12 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Bolt Biotherapeutics, Inc. logo
BOLT

Bolt Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (30 total)

  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Sep 18, 2026
    Sale(S)
    Direct
    6.9K shares at avg. $3.24$22K
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Sep 17, 2026
    Sale(S)
    Direct
    4.9K shares at avg. $3.32$16K
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Sep 16, 2026
    Sale(S)
    Direct
    1.4K shares at avg. $3.77$5K
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Jan 28, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    10K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    17.5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    7.7K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    17.5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    3.2K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    3.2K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    660 shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    660 shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    822 shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    822 shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    4.6K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    4.6K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    2.1K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    2.1K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    9.5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    9.5K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    11.4K shares-
  • Bolt Biotherapeutics, Inc. logo
    BOLT

    Bolt Biotherapeutics, Inc.

    Dec 12, 2025
    Disposition(D)

    Employee Stock Option (Right to Buy)

    Direct
    11.4K shares-

1-25 of 30

About Yonehiro Grant

Yonehiro Grant (SEC CIK 0001428666) files insider reports with the SEC as Chief Operating Officer of Bolt Biotherapeutics, Inc. (BOLT).

Signal8 holds 5 ownership filings by Yonehiro Grant, all Form 4s, filed between May 5, 2025 and Sep 21, 2026. Those filings report 30 transactions, from May 1, 2025 to Sep 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Yonehiro Grant's filings is in REDWOOD CITY, CA.

Recent filings by Yonehiro Grant

  • Sep 18, 2026: Open-market sale of BOLT shares (Form 4, code S).
  • Sep 17, 2026: Open-market sale of BOLT shares (Form 4, code S).
  • Sep 16, 2026: Open-market sale of BOLT shares (Form 4, code S).
  • Jan 28, 2026: Grant or award of BOLT derivative securities (Form 4, code A).
  • Dec 12, 2025: Disposition to issuer transactions of BOLT derivative securities (2 lines, Form 4, code D).

Other insiders filing for Bolt Biotherapeutics, Inc. (BOLT)

How to read Form 4 transaction codes